Lurie Cancer Center Funds Supporting Investigator-Initiated Clinical/Translational Studies
Supports innovative, investigator-initiated clinical and translational cancer research at Northwestern's Lurie Cancer Center to generate preliminary data for future large-scale national funding.
Funder: Northwestern University
Due Dates: Rolling (applications reviewed bimonthly)
Funding Amounts: Up to $50,000 per study; funding increases may be considered case-by-case; award duration up to 5 years.
Summary: Supports innovative, investigator-initiated clinical and translational cancer research at the Lurie Cancer Center to generate preliminary data for larger, nationally funded studies.
Key Information: Must be a Lurie Cancer Center investigator; SRC approval required before applying.
Description
This funding mechanism from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University supports underfunded or unfunded, highly innovative, investigator-initiated clinical trials and novel translational research. The primary goal is to help Lurie Cancer Center investigators generate foundational data for future, larger-scale, nationally funded studies (e.g., NIH, NCI). Emphasis is placed on projects that bridge laboratory discoveries and clinical applications, and on studies that align with the Cancer Center’s strategic priorities. Funding is intended to facilitate investigator-initiated trials, correlative studies conducted with clinical protocols, and projects where Lurie Cancer Center faculty play a major role.
